3D Biotek
3D Biotek LLC is a New Jersey-based biotech company that designs and sells proprietary 3D porous polymer scaffolds, perfusion bioreactors, and a large-scale cell expansion system for academic researchers, pharmaceutical firms, and biotech companies in stem cell, tissue engineering, and drug discovery applications.
- Company typePrivate
- Founded2007
- HeadquartersBridgewater, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What 3D Biotek does
3D Biotek LLC is a New Jersey-based biotechnology company founded in April 2007 that designs, manufactures, and sells novel 3D cell culture devices and bioreactor systems for research and biomedical applications. The company's core offerings are built on a proprietary Precision 3D Micro-Fabrication Technology platform that produces porous polymer scaffolds — 3D Insert-PCL (biodegradable polycaprolactone) and 3D Insert-PS (polystyrene) — with 100% open porosity, well-defined pore sizes, and batch-to-batch reproducibility. These scaffolds integrate with the 3D Perfusion Bioreactor for dynamic culture, and the company also sells HA Discs for bone research and the 3D Cell Expansion System (3D-CES), an integrated bioreactor/incubator registered with the US FDA as a Class I medical device capable of producing up to 500 million anchorage-dependent cells per production run in 14-18 days. Contract lab services and custom manufacturing services (including medical device prototyping and stent fabrication) round out the portfolio.
The company serves academic researchers, pharmaceutical drug discovery groups, and biotech firms working in stem cell expansion, tissue engineering, cancer research, and drug screening. It is US FDA registered and ISO-13485-2016 certified (since May 2019), with a GMP facility established in 2017. 3D Biotek distributes products through a global network of regional distributors covering North America, Europe, Asia, and Africa, complemented by direct e-commerce via 3dbiotekstore.com and conference-driven demand generation. Following a 100% equity acquisition by Hong Kong-based Mega Hill Corporation Limited in October 2015, the company has continued to operate from New Jersey (currently in Warren, NJ) with a 1-10 employee headcount, supplemented by multiple federal and state grants (NSF, SBIR/NIH, Edison, NJCST) over its history.
3D Biotek firmographics
Firmographics- Name
- 3D Biotek
- Legal name
- 3D Biotek LLC
- Website
- https://3dbiotek.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- 3D Biotek LLC is a New Jersey-based biotech company that designs and sells proprietary 3D porous polymer scaffolds, perfusion bioreactors, and a large-scale cell expansion system for academic researchers, pharmaceutical firms, and biotech companies in stem cell, tissue engineering, and drug discovery applications.
- Ownership category
- akta.pro rank
3D Biotek industry classification
Industry- Product category
- 3D Cell Culture Devices and Biomedical Research Tools
- NAICS
- Medical Equipment and Supplies Manufacturing (33911)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB)
- akta.pro secondary industries
- Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), Medical & Dental Prototyping (Models, Guides, Pre-Op Planning) (IMAAAFAI)
Keywords
Where 3D Biotek is headquartered
LocationHeadquarters
- HQ city
- Bridgewater
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
3D Biotek business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales
Revenue model
- 3D Cell Culture Products: Sale of 3D Insert scaffolds (PCL and PS), HA Discs, 3D Bioreactors, and 3D Cell Expansion Systems to research institutions, pharmaceutical companies, and biotech firms.
- Contract Lab Services: Custom laboratory services including custom design, product prototyping, consulting, and regulatory filing support. Services include 3D toxicity assays for cancer and drug screening using various cell lines.
- Manufacturing Services: Custom design and fabrication of 3D cell culture/tissue engineering scaffolds, medical device prototyping, and Rapid Stent Fabrication System for bioabsorbable porous tubular structures.
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
3D Biotek product offering
Product offeringCore offering
3D Biotek manufactures and sells novel 3D porous scaffold inserts (PCL and PS), the 3D Cell Expansion System (3D-CES) bioreactor/incubator, 3D Perfusion Bioreactors, and HA Discs for 3D cell culture, stem cell expansion, and tissue engineering research. It also provides Contract Lab Services and custom Manufacturing Services for medical device prototyping and tissue engineering scaffolds.
Product overview
3D Biotek offers a portfolio of 3D cell culture products and biomedical manufacturing services. The core product line consists of 3D Insert scaffolds (available in both biodegradable PCL and non-biodegradable PS materials), which serve as the foundational 3D cell culture platform. These scaffolds integrate with the 3D Perfusion Bioreactor for dynamic culture applications. The 3D Cell Expansion System (3D-CES) represents the company's integrated bioreactor/incubator system for large-scale stem cell expansion. HA Discs address bone research applications. The company also provides Contract Lab Services and Manufacturing Services for custom scaffold fabrication and medical device prototyping. The Precision 3D Micro-Fabrication Technology platform underpins the entire product portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- 3D Insert: Series of novel 3D porous scaffolds for drug screening, stem cell research, and tissue engineering.
- 3D Cell Expansion System (3D-CES)
Products and services
- 3D Insert-PCL 3D porous scaffolds fabricated from polycaprolactone (PCL), a biodegradable polymer used in FDA-approved implants. Prepackaged into tissue culture plates ranging from 6-well to 96-well formats, terminally sterilized by gamma radiation. Designed for researchers in drug screening, stem cell research, and tissue engineering who need biodegradable 3D culture substrates.
- 3D Insert-PS 3D porous scaffolds fabricated from polystyrene, the same material as traditional tissue culture plates. Prepackaged into tissue culture plates (6-well to 96-well), terminally sterilized, and transparent for direct monitoring of cell growth under inverted microscope. Targeted at researchers needing non-biodegradable, microscope-compatible 3D culture substrates.
- 3D Cell Expansion System (3D-CES) Integrated bioreactor/incubator system for large-scale expansion of anchorage-dependent cells in a 3D micro-environment. Features 2-chamber design allowing expansion of up to 500 million cells per production run in approximately 14-18 days. Registered with US FDA as a Class I medical device. Designed for bio-banking, stem cell therapy, and exosome production applications.
- 3D Perfusion Bioreactor 3D perfusion bioreactor with multiple independent autoclavable polycarbonate chambers designed to work with 3D Insert scaffolds (24-well, 12-well, 6-well sizes). Media is perfused through porous scaffold structure using a peristaltic pump for dynamic cell culture. Targeted at researchers needing dynamic perfusion culture for tissue engineering and drug screening.
- HA Disc Hydroxyapatite discs made from 100% synthetic material for bone-related research including osteoporosis, bone matrix mineralization, tissue calcification, and bone defect repair. Pre-sterilized and individually packaged using gamma radiation. Targeted at researchers in bone biology and orthopedic tissue engineering.
- 3D Cell Transfection Kit Product launched in April 2010 for conducting 3D cell transfection experiments, introduced alongside the BioCellChallenge partnership.
- Contract Lab Services Custom laboratory services including design, product prototyping (medical devices, tissue engineering), and regulatory consulting. Includes 3D toxicity assays for cancer and drug screening using cell lines such as MCF-7, HepG2, Fibroblasts, Keratinocytes, Osteoblasts, and Stem Cells. Targeted at pharmaceutical and biotech R&D teams needing outsourced 3D cell culture expertise.
- Manufacturing Services Custom design and fabrication of 3D cell culture and tissue engineering scaffolds using patented 3D Precision Micro-Fabrication Technology. Also includes medical device prototyping and the Rapid Stent Fabrication (RSF) System for bioabsorbable porous tubular structures. Targeted at medical device companies and tissue engineering groups needing custom scaffold manufacturing.
Quantifiable outcome
- 200-300 million cells expanded per chamber in 14-18 days
- +2 more outcomes
Companies that use 3D Biotek
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
3D Biotek technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
3D Biotek partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- Stevens Institute of TechnologyminorCollaborative research partnership for NSF Phase I Grant awarded in 2014 for developing biomimetic nanofiber coating on dental implants for gingival regeneration.
- KIYATECminor3D Biotek and KIYATEC formed a strategic partnership in December 2011 to launch synergistic 3D cell culture products. The collaboration introduced preassembled, single-use disposable scaffolds with plasticware preloads as an industry first.
- BioCellChallengeminorPartnership with BioCellChallenge SAS for distribution of 3D Biotek products and launch of 3D Cell Transfection Kit in April 2010.
Scale indicators2 records
Recent moves9 records
Expansion highlights6 records
3D Biotek competitors and assessment
Company assessmentEmerging players
- Emulate: US-based organ-on-chip technology company targeting pharmaceutical drug discovery. Adjacent competitor to 3D Biotek in 3D cell culture for drug screening, with a different technological approach using microfluidic chips.
- Bico (formerly CELLINK): Swedish company specializing in bioprinting technology and 3D cell culture products. Comparable to 3D Biotek in 3D culture and tissue engineering, with additional focus on bioprinters and bioinks.
- CN Bio: UK-based organ-on-chip and 3D cell culture company providing single- and multi-organ microphysiological systems. Adjacent competitor to 3D Biotek in 3D cell culture for drug discovery applications.
- Organovo: US-based 3D bioprinting company developing functional human tissues for drug discovery and therapeutic applications. Comparable to 3D Biotek in tissue engineering and 3D cell culture space, with bioprinting-centric approach.
Direct peers
- InSphero: Swiss company specializing in 3D cell culture technology, organoids, and microtissue-based drug discovery platforms. Most directly comparable to 3D Biotek in serving stem cell and drug discovery researchers with 3D culture tools.
- Mimetas: Dutch company providing organ-on-chip and 3D tissue models for drug discovery. Comparable to 3D Biotek in targeting pharmaceutical researchers with 3D culture platforms, though focused on microfluidic organ-on-chip rather than porous scaffolds.
- REPROCELL: Japan-based provider of 3D cell culture and stem cell research tools, including scaffold-based products for regenerative medicine and drug screening. Direct overlap with 3D Biotek in 3D culture products for stem cell and tissue engineering applications.
Broad incumbents
- Corning Life Sciences: Major life science tools manufacturer offering a broad portfolio of cell culture products including spheroid microplates and Corning Matrigel matrix. Competes with 3D Biotek in 3D cell culture but as part of a much wider catalog rather than a 3D-focused specialist.
- Lonza: Major cell and gene therapy manufacturing services provider with bioreactor and cell expansion capabilities. Comparable to 3D Biotek in the cell expansion and tissue engineering space, but operates at significantly larger scale as a CDMO.
- Thermo Fisher Scientific: Global life science tools leader with extensive cell culture, bioreactor, and 3D culture product lines (Gibco, Nunc). Competes with 3D Biotek through broad portfolio and bundled offerings to pharma and academic customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
3D Biotek social profiles
Digital presence3D Biotek compliance and trust
Trust signalCompliance2 records
3D Biotek financial estimates
Financial estimateRevenue estimate
Valuation estimate
3D Biotek leadership team
Management profileNumber of profiles
Profiles4 records
3D Biotek funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
3D Biotek M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 3D Biotek
What does 3D Biotek do?
3D Biotek manufactures and sells novel 3D porous scaffold inserts (PCL and PS), the 3D Cell Expansion System (3D-CES) bioreactor/incubator, 3D Perfusion Bioreactors, and HA Discs for 3D cell culture, stem cell expansion, and tissue engineering research. It also provides Contract Lab Services and custom Manufacturing Services for medical device prototyping and tissue engineering scaffolds.
Is 3D Biotek a public or private company?
3D Biotek is a private company. It is classified as corporate owned and is currently operating.
When was 3D Biotek founded?
3D Biotek was founded in 2007. It employs 1 to 10 people.
Where is 3D Biotek based?
3D Biotek is headquartered in Bridgewater, United States, in the North America region.
How does 3D Biotek make money?
Three revenue lines are on record. 3D Cell Culture Products are the primary driver. The others are contract Lab Services and manufacturing Services.
Who are 3D Biotek's main competitors?
Emerging players on record are Emulate, Bico (formerly CELLINK), CN Bio and Organovo. Direct peers are InSphero, Mimetas and REPROCELL. Broad incumbents are Corning Life Sciences, Lonza and Thermo Fisher Scientific.
Does 3D Biotek have an API?
No public API is recorded for 3D Biotek.
What industry is 3D Biotek in?
3D Biotek's product category is 3D Cell Culture Devices and Biomedical Research Tools. Its primary akta.pro industry code is HLAAAGAB, Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials), with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 33911 and its SIC code is 3841.